I'm sure they will announce a new VP of regulatory in the very near future, unless they are going to outsource the function. If a recognized 'star' is recruited then that may pump the SP by a few pennies
They do need a highly experienced person to deal with the NB, and in the near future the FDA.
I've seen too many companies screw up on this as they think it is 'easy' - it is not.
I'm sure they will announce a new VP of regulatory in the very...
-
- There are more pages in this discussion • 97 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add OSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.001(7.69%) |
Mkt cap ! $52.97M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.3¢ | $56.50K | 4.041M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 17 | 12011630 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 6141425 | 9 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| OSL (ASX) Chart |